J Korean Acad Fam Med.  2002 Sep;23(9):1114-1123.

The Predictors of Growth Hormone Secretion after L-dopa Stimulation Test in Adults

Affiliations
  • 1Department of Family Medicine, Miz Medi Hospital, Korea.
  • 2Department of Internal Medicine, Miz Medi Hospital, Korea. love0614@yumc.yonsei.ac.kr
  • 3Department of Family Medicine, Young-dong Severance Hospital, Korea.
  • 4Department of Family Medicine, Eul Ji University Hospital, Korea.

Abstract

BACKGROUND: Twenty four-hour GH secretion reaches a peak in puberty and declines by 14% every decade in adult life. By age 60, most adults have a total 24-hour secretion rate indistinguishable from those of hypopituitary patients with organic lesions in pituitary gland. We performed this study to know about the predictors of GH secretion after L-dopa stimulation test in adults.
METHODS
One hundred and ninety eight patients over the age of 45, who visited the menopausal clinic from Oct. 2001 to May 2002, were studied. We compared the peak GH value after the administration of L-dopa 500 mg by gender and age groups. Also, we compared the GH deficiency group to normal by anthropometric and measured variables.
RESULTS
The mean of the stimulated GH peak value and the prevalence rate of growth hormone deficiency were greater in women than in men. GH-AUC after L-dopa stimulation correlated well with all measurements of adiposity. In GH deficiency group, the mean values of measured variables about adiposity were greater than normal in statistical significance. Logistic regression test revealed sex and abdominal obesity contributed significantly to predict GH deficiency after L-dopa stimulation test. The odds ratio of GH deficiency were 3.0 in women compared to men with 2.9 in abdominal obesity.
CONCLUSION
Gender and adiposity were the predictors of GH deficiency in adults after L-dopa stimulation test rather than age and IGF-1 values.

Keyword

growth hormone deficiency in adults; growth hormone; somatopause; aging

MeSH Terms

Adiposity
Adolescent
Adult*
Aging
Female
Growth Hormone*
Humans
Insulin-Like Growth Factor I
Levodopa*
Logistic Models
Male
Obesity, Abdominal
Odds Ratio
Pituitary Gland
Prevalence
Puberty
Growth Hormone
Insulin-Like Growth Factor I
Levodopa
Full Text Links
  • KJFM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr